Dr. Faramand is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
12902 Usf Magnolia Dr
Tampa, FL 33612Phone+1 703-328-6110- Is this information wrong?
Education & Training
University of South Florida MorsaniFellowship, Hematology and Medical Oncology, 2016 - 2019
University of MarylandResidency, Internal Medicine, 2012 - 2015
Virginia Commonwealth University School of MedicineClass of 2012
Certifications & Licensure
FL State Medical License 2016 - 2026
MD State Medical License 2015 - 2016- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies Start of enrollment: 2022 Jun 21
Roles: Contact
- A Phase 1/2 Study of the Safety and Efficacy of Anti-CD7 Allogeneic CAR-T Cells (WU-CART-007) in Patients With Relapsed or Refractory T-ALL/LBL Start of enrollment: 2022 Jan 14
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Mismatched donor allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide achieves comparable outcomes between racially and ethnically diver...Teresa Caprice, Wenyi Fan, Jongphil Kim, Rawan Faramand, Asmita Mishra, Lia Perez, Farhad Khimani, Aleksandr Lazar-Yan, Jose L Ochoa-Bayona, Hien Liu, Michael D Jain, ...> ;American Journal of Hematology. 2024 Mar 28
- Baseline Serum Inflammatory Proteins Predict Poor CAR T Outcomes in Diffuse Large B-cell Lymphoma.Dean, E., Rawan G Faramand, Sae Bom Lee, Michael D Jain, Biwei Cao, Xuefeng Wang, Kai Rejeski, Marion Subklewe, Johannes F Fahrmann, Neeraj Y Saini, Samir M Hanash, Yu...> ;Blood Cancer Discovery. 2024 Mar 1
- Hypomethylating Agents and Venetoclax for Acute Myeloid Leukemia Relapsed After Hematopoietic Stem Cell Transplant.Ionescu, F., David, J., Ravichandran, A., Sallman, D., Sweet, K., Komrokji, R., Chan, O., Kuykendall, A., Padron, E., Faramand, R., Bejanyan, N., Khimani, F., Elmariah...> ;Clinical Lymphoma, Myeloma & Leukemia. 2024 Feb 12
- Join now to see all
Abstracts/Posters
- Tumor Inflammation and Myeloid Derived Suppressor Cells Reduce the Efficacy of CD19 CAR T Cell Therapy in LymphomaRawan Faramand, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Impact of TBI-Based Conditioning Regimen on Outcomes of Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplant: Systematic Revi...Rawan Faramand, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- The Lymphoma Tumor Microenvironment Influences Toxicity after CD19 CAR T Cell TherapyRawan Faramand, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
- Moffitt Researchers Identify Factors to Predict Severe Toxicities in CAR T PatientsJuly 15th, 2020
Risk Stratification Can Predict Outcomes for CAR T-cell Therapy in LymphomaFebruary 16th, 2024
Hospital Affiliations
H. Lee Moffitt Cancer Center and Research InstituteTampa, Florida
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
